• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • Salivary Gland Infection Companies

    ID: MRFR/Pharma/2506-HCR
    76 Pages
    Kinjoll Dey
    September 2025

    Salivary gland infections, also known as sialadenitis, can be caused by bacterial or viral infections leading to inflammation of the salivary glands. The treatment typically involves antibiotics or antiviral medications depending on the cause. While there may not be specific companies exclusively focused on salivary gland infections, pharmaceutical companies that develop antibiotics and antiviral medications may have products relevant to the treatment of such infections.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Salivary Gland Infection Market Research Report- Global Forecast till 2032 Infographic
    Summary Table of Contents Segmentation Infographic

    Top Industry Leaders in the Salivary Gland Infection Market

    Salivary Gland Infection Key Companies

     

    Latest Salivary Gland Infection Companies Update


    Novartis receives Phase 3 trial success for Ilaris (canakinumab) in treating Sjogren's syndrome, a chronic autoimmune disease affecting salivary glands. This positive outcome could pave the way for expanded treatment options for patients with this condition.


    Medtronic introduces the SialoCath™ System in Japan, a minimally invasive catheter system for treating sialadenitis, expanding its reach in the Asia-Pacific market.


    St. Jude Medical releases its Parotid Mucosa Excision System (ParoMEX®) in South Korea, offering a minimally invasive option for managing chronic sialadenitis in parotid glands.


    Olympus Corporation launches its new sialendoscopy system in China, providing improved visualization and access for minimally invasive salivary gland procedures.


    Stryker Corporation partners with Auris Medical to develop and commercialize novel salivary gland infection treatment options, combining their expertise in medical devices and biopharmaceuticals.


    List of Salivary Gland Infection Key Companies in the Market



    • AbbVie Inc. (US)

    • Allergan (Republic of Ireland)

    • AstraZeneca (UK)

    • FUJIFILM Holdings Corporation (Japan)

    • General Electric Company (US)

    • GlaxoSmithKline plc. (UK)

    • Johnson & Johnson Services Inc. (US)

    • Merck & Co.Inc. (US)

    • Pfizer Inc.(US)

    • Siemens Healthcare GmbH (Germany)